What is the ₹1,000 Crore MedTech Fund?
India’s first dedicated MedTech investment fund is being established by a group of industry experts and investors led by Ganesh Sabat, the former CEO of Sahajanand Medical Technologies (SMT). The fund aims to provide growth-stage capital to companies in the medical technology sector and accelerate the development of locally manufactured medical devices.
The fund targets a corpus of approximately ₹1,000 crore and focuses on supporting companies that have already demonstrated product-market fit but require additional capital and operational expertise to scale up their manufacturing and expand their market presence.
By providing strategic investment and industry guidance, the fund aims to help Indian MedTech companies compete more effectively in a global market that is currently dominated by international manufacturers.
Why India Needs a Dedicated MedTech Investment Fund
The Indian medical technology industry has grown steadily in recent years, driven by rising healthcare demand, technological innovation, and supportive government initiatives. However, many domestic companies still face challenges such as limited access to capital, high research and development costs, and heavy reliance on imported components.
A dedicated investment fund can address these challenges by:
- Providing capital for product development and manufacturing expansion
- Supporting commercialization of innovative medical devices
- Encouraging domestic production under national manufacturing initiatives
- Helping companies scale operations and enter international markets
The new fund aims to bridge the financing gap that often exists between early-stage startup funding and large-scale institutional investment.
Focus on Growth-Stage MedTech Companies
Unlike traditional venture capital funds that primarily invest in early-stage startups, this MedTech fund is designed as a growth-stage investment platform.
The target companies are typically those generating revenues between ₹30 crore and ₹80 crore and looking to expand their operations or manufacturing capacity.
These companies often require not only funding but also operational expertise, industry connections, and strategic guidance to achieve large-scale production and global competitiveness.
By focusing on this segment, the fund aims to accelerate the growth of promising MedTech firms that are already on a strong trajectory.
Supporting the “Make in India” Healthcare Vision
One of the key objectives of the fund is to strengthen domestic medical device manufacturing and align with national initiatives such as “Make in India,” which promotes local production across multiple industries.
India currently imports a significant share of advanced medical equipment, which increases healthcare costs and limits local technological capabilities. Encouraging domestic manufacturing can reduce import dependency while creating jobs and improving healthcare accessibility.
Investments from the fund are expected to support companies working on a range of medical technologies, including:
- Diagnostic devices
- Surgical equipment
- Implantable devices
- Digital health technologies
- Hospital equipment and monitoring systems
Strengthening local manufacturing capacity will also enable Indian companies to compete in international markets.
Building a Strong MedTech Ecosystem in India
The launch of a dedicated MedTech fund represents a major step toward building a comprehensive medical technology ecosystem in India. The country already hosts several initiatives designed to support healthcare innovation.
For example, the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam serves as a large medical technology manufacturing hub that provides shared infrastructure and research facilities for device manufacturers.
Such initiatives create a supportive environment for companies developing advanced healthcare technologies, from research and prototyping to manufacturing and commercialization.
The new investment fund is expected to complement these infrastructure initiatives by providing the financial support needed for companies to scale their operations.
Impact on Healthcare Innovation and Access
Access to affordable medical devices is a critical component of improving healthcare outcomes in India. As local manufacturers receive greater financial support, they can develop technologies that are better suited to local healthcare challenges and resource conditions.
Potential long-term benefits of this investment initiative include:
- Lower cost of medical equipment due to local manufacturing
- Increased innovation in healthcare technologies
- Greater availability of advanced medical devices in hospitals
- Enhanced export opportunities for Indian MedTech companies
By enabling domestic firms to scale production and develop new technologies, the fund could help improve both the quality and accessibility of healthcare services.
Strengthening India’s Position in the Global MedTech Market
Globally, the medical technology sector is one of the fastest-growing areas within healthcare. Countries that invest heavily in MedTech research, manufacturing, and innovation often become global leaders in medical devices and healthcare technology.
India’s large patient base, growing healthcare infrastructure, and expanding startup ecosystem provide a strong foundation for MedTech innovation. Strategic funding initiatives like this ₹1,000 crore investment fund can accelerate the development of a globally competitive MedTech industry.
With the right mix of capital, research support, and regulatory reforms, India has the potential to become a significant player in the global medical technology market.
Summing up: The launch of India’s first dedicated ₹1,000 crore MedTech investment fund marks an important milestone for the country’s healthcare technology sector. By providing growth-stage funding and industry expertise, the initiative aims to accelerate innovation, strengthen domestic manufacturing, and reduce dependence on imported medical devices.
As India continues to expand its healthcare infrastructure and invest in technology-driven solutions, initiatives like this fund could play a crucial role in shaping the future of the nation’s MedTech ecosystem.
In the coming years, increased collaboration between investors, industry leaders, and policymakers may help position India as a global hub for affordable and innovative medical technologies.